SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001493152-24-003291
Filing Date
2024-01-22
Accepted
2024-01-22 17:00:49
Documents
7

Document Format Files

Seq Description Document Type Size
1 forms-3.htm S-3 271297
2 ex5-1.htm EX-5.1 52452
3 ex23-1.htm EX-23.1 7364
4 ex107.htm EX-FILING FEES 71518
5 forms-3_001.jpg GRAPHIC 48758
6 ex23-1_001.jpg GRAPHIC 6954
7 ex23-1_002.jpg GRAPHIC 3338
  Complete submission text file 0001493152-24-003291.txt   485470
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: S-3 | Act: 33 | File No.: 333-276650 | Film No.: 24549553
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)